Interleukin-2 inhibits HIV-1 replication in some human T cell lymphotrophic virus-1-infected cell lines via the induction and incorporation of APOBEC3G into the virion

Journal of Biological Chemistry

Volumn 288, Issue 24, 2013, Pages 17812-17822

  Oguariri, Raphael M ^a   Dais, Lue ^a   Adelsberger, Joseph W ^a   Ruperts, Adam ^a   Stevens, Randy ^a   Yang, Jun ^a   Huang, Dawei ^a   Lempicki, Richard A ^a   Zhou, Ming ^b   Baseler, Michael W ^a   Lane, H Clifford ^c   Imamichi, Tomozumi ^a  

^a FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN T CELL LYMPHOTROPHIC VIRUS; HUMAN T CELLS; INHIBITORY EFFECT; INTERLEUKIN-2; MT-2 CELLS; PRODUCTION OF; REAL-TIME PCR; WESTERN-BLOT ANALYSIS;

CELL CULTURE; CELL PROLIFERATION; CELLS; VIRUSES;

DISEASES;

ANTIGEN P24; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; INTERLEUKIN 2; INTERLEUKIN 27;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; FAST PROTEIN LIQUID CHROMATOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VIRION; VIRUS INHIBITION; VIRUS REPLICATION; WESTERN BLOTTING;

CYTOKINE; GAMMA CHAIN CYTOKINES; HIV-1; HOST DEFENSE; HOST RESTRICTION FACTORS; HTLV-1; IL-2; IMMUNOLOGY; INTERLEUKIN; VIRAL REPLICATION;

ANTIGENS, CD4; CELL LINE; CYTIDINE DEAMINASE; ENZYME INDUCTION; GENE KNOCKDOWN TECHNIQUES; HIV-1; HUMANS; INTERLEUKIN-2; MUTATION; RECEPTORS, CXCR4; REVERSE TRANSCRIPTION; RNA, SMALL INTERFERING; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES; TRANSCRIPTIONAL ACTIVATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 84879048662     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.468975     Document Type: Article

References (67)

1. Kaslow, R. A., Carrington, M., Apple, R., Park, L., Muñoz, A., Saah, A. J., Goedert, J. J., Winkler, C., O'Brien, S. J., Rinaldo, C., Detels, R., Blattner, W., Phair, J., Erlich, H., and Mann, D. L. (1996) Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 2, 405-411 (Pubitemid 26193012)
2. Carrington, M., Nelson, G. W., Martin, M. P., Kissner, T., Vlahov, D., Goedert, J. J., Kaslow, R., Buchbinder, S., Hoots, K., and O'Brien, S. J. (1999) HLA and HIV-1. Heterozygote advantage and B*35-Cw*04 disadvantage. Science 283, 1748-1752
3. Kiepiela, P., Leslie, A. J., Honeyborne, I., Ramduth, D., Thobakgale, C., Chetty, S., Rathnavalu, P., Moore, C., Pfafferott, K. J., Hilton, L., Zimbwa, P., Moore, S., Allen, T., Brander, C., Addo, M. M., Altfeld, M., James, I., Mallal, S., Bunce, M., Barber, L. D., Szinger, J., Day, C., Klenerman, P., Mullins, J., Korber, B., Coovadia, H. M., Walker, B. D., and Goulder, P. J. (2004) Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432, 769-775
4. Saifuddin, M., Roebuck, K. A., Chang, C., Ting, J. P., and Spear, G. T. (2000) Cutting edge. Activation of HIV-1 transcription by the MHC class II transactivator. J. Immunol. 164, 3941-3945 (Pubitemid 30215044)
5. Berger, E. A., Murphy, P. M., and Farber, J. M. (1999) Chemokine receptors as HIV-1 coreceptors. Roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17, 657-700 (Pubitemid 29241137)
6. Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., and Trono, D. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99-103 (Pubitemid 36834849)
7. Sheehy, A. M., Gaddis, N. C., Choi, J. D., and Malim, M. H. (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650
8. Neil, S. J., Zang, T., and Bieniasz, P. D. (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425-430 (Pubitemid 351158893)
9. Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., and Benkirane, M. (2011) SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654-657
10. Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., and Skowronski, J. (2011). Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474, 658-661
11. Fakruddin, J. M., Lempicki, R. A., Gorelick, R. J., Yang, J., Adelsberger, J. W., Garcia-Pineres, A. J., Pinto, L. A., Lane, H. C., and Imamichi, T. (2007) Noninfectious papilloma virus-like particles inhibit HIV-1 replication. Implications for immune control of HIV-1 infection by IL-27. Blood 109, 1841-1849 (Pubitemid 46348178)
12. Xiang, J., George, S. L., Wünschmann, S., Chang, Q., Klinzman, D., and Stapleton, J. T. (2004) Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1α, MIP-1α, and SDF-1. Lancet 363, 2040-2046 (Pubitemid 38781104)
13. Hou, W., Wang, X., Ye, L., Zhou, L., Yang, Z. Q., Riedel, E., and Ho, W. Z. (2009) Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages. J. Virol. 83, 3834-3842
14. Poli, G., Bressler, P., Kinter, A., Duh, E., Timmer, W. C., Rabson, A., Justement, J. S., Stanley, S., and Fauci, A. S. (1990) Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor α by transcriptional and post-transcriptional mechanisms. J. Exp. Med. 172, 151-158 (Pubitemid 20217256)
15. Folks, T. M., Clouse, K. A., Justement, J., Rabson, A., Duh, E., Kehrl, J. H., and Fauci, A. S. (1989) Tumor necrosis factor α induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. U.S.A. 86, 2365-2368 (Pubitemid 19102509)
16. Foli, A., Saville, M. W., Baseler, M. W., and Yarchoan, R. (1995) Effects of the Th1 and Th2 stimulatory cytokines interleukin-12 and interleukin-4 on human immunodeficiency virus replication. Blood 85, 2114-2123
17. Kalter, D. C., Nakamura, M., Turpin, J. A., Baca, L. M., Hoover, D. L., Dieffenbach, C., Ralph, P., Gendelman, H. E., and Meltzer, M. S. (1991) Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. J. Immunol. 146, 298-306
18. Perno, C. F., Cooney, D. A., Gao, W. Y., Hao, Z., Johns, D. G., Foli, A., Hartman, N. R., Caliò, R., Broder, S., and Yarchoan, R. (1992) Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages. Blood 80, 995-1003
19. Chun, T. W., Engel, D., Mizell, S. B., Ehler, L. A., and Fauci, A. S. (1998) Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines. J. Exp. Med. 188, 83-91 (Pubitemid 28328608)
20. Poli, G., and Fauci, A. S. (1993) Cytokine modulation of HIV expression. Semin. Immunol. 5, 165-173
21. Fauci, A. S. (1996) Host factors and the pathogenesis of HIV-induced disease. Nature 384, 529-534
22. Malim, M. H. (2009) APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos. Trans. R. Soc. Lond. B Biol. Sci. 364, 675-687
23. Bishop, K. N., Holmes, R. K., and Malim, M. H. (2006) Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J. Virol. 80, 8450-8458 (Pubitemid 44384857)
24. Holmes, R. K., Koning, F. A., Bishop, K. N., and Malim, M. H. (2007) APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G. J. Biol. Chem. 282, 2587-2595 (Pubitemid 47076764)
25. Newman, E. N., Holmes, R. K., Craig, H. M., Klein, K. C., Lingappa, J. R., Malim, M. H., and Sheehy, A. M. (2005) Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr. Biol. 15, 166-170
26. Stopak, K., de Noronha, C., Yonemoto, W., and Greene, W. C. (2003) HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell 12, 591-601 (Pubitemid 37222482)
27. Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., and Yu, X. F. (2003) Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302, 1056-1060 (Pubitemid 37386201)
28. Kobayashi, M., Takaori-Kondo, A., Miyauchi, Y., Iwai, K., and Uchiyama, T. (2005) Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function. J. Biol. Chem. 280, 18573-18578 (Pubitemid 41379555)
29. Mehle, A., Strack, B., Ancuta, P., Zhang, C., McPike, M., and Gabuzda, D. (2004) Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J. Biol. Chem. 279, 7792-7798 (Pubitemid 38294663)
30. Imamichi, T., Yang, J., Huang, D. W., Brann, T. W., Fullmer, B. A., Adelsberger, J. W., Lempicki, R. A., Baseler, M. W., and Lane, H. C. (2008) IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages. AIDS 22, 39-45 (Pubitemid 350294876)
31. Greenwell-Wild, T., Vázquez, N., Jin, W., Rangel, Z., Munson, P. J., and Wahl, S. M. (2009) Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon. Blood 114, 1864-1874
32. Dai, L., Lidie, K. B., Chen, Q., Adelsberger, J. W., Zheng, X., Huang, D., Yang, J., Lempicki, R. A., Rehman, T., Dewar, R. L., Wang, Y., Hornung, R. L., Canizales, K. A., Lockett, S. J., Lane, H. C., and Imamichi, T. (2013) IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation. J. Exp. Med. 210, 517-534
33. Chen, Q., Swaminathan, S., Yang, D., Dai, L., Sui, H., Yang, J., Hornung, R. L., Wang, Y., Huang da, W., Hu, X., Lempicki, R. A., and Imamichi, T. (2013) Interleukin-27 is a potent inhibitor of cis HIV-1 replication in monocyte-derived dendritic cells via a type I interferon-independent pathway. PLoS One 8, e59194
34. Swaminathan, S., Hu, X., Zheng, X., Kriga, Y., Shetty, J., Zhao, Y., Stephens, R., Tran, B., Baseler, M. W., Yang, J., Lempicki, R. A., Huang, D., Lane, H. C., and Imamichi, T. (2013) Interleukin-27 treated human macrophages induce the expression of novel microRNAs which may mediate anti-viral properties. Biochem. Biophys. Res. Commun. 434, 228-234
35. Haertle, T., Carrera, C. J., Wasson, D. B., Sowers, L. C., Richman, D. D., and Carson, D. A. (1988) Metabolism and anti-human immunodeficiency virus- 1 activity of 2-halo-2′,3′-dideoxyadenosine derivatives. J. Biol. Chem. 263, 5870-5875
36. Harada, S., Koyanagi, Y., and Yamamoto, N. (1985) Infection of HTLVIII/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229, 563-566 (Pubitemid 16239336)
37. Larder, B. A., Darby, G., and Richman, D. D. (1989) HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243, 1731-1734 (Pubitemid 19106971)
38. Pauwels, R., De Clercq, E., Desmyter, J., Balzarini, J., Goubau, P., Herdewijn, P., Vanderhaeghe, H., and Vandeputte, M. (1987) Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus. J. Virol. Methods 16, 171-185 (Pubitemid 17114161)
39. Gallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R., Oleske, J., and Safai, B. (1984) Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224, 500-503 (Pubitemid 14134741)
40. Zheng, Y. H., Irwin, D., Kurosu, T., Tokunaga, K., Sata, T., and Peterlin, B. M. (2004) Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J. Virol. 78, 6073-6076 (Pubitemid 38661697)
41. Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A., and Martin, M. A. (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284-291 (Pubitemid 16013975)
42. Imamichi, T., Murphy, M. A., Adelsberger, J. W., Yang, J., Watkins, C. M., Berg, S. C., Baseler, M. W., Lempicki, R. A., Guo, J., Levin, J. G., and Lane, H. C. (2003) Actinomycin D induces high-level resistance to thymidine analogs in replication of human immunodeficiency virus type 1 by interfering with host cell thymidine kinase expression. J. Virol. 77, 1011-1020 (Pubitemid 36055523)
43. Oguariri, R. M., Brann, T. W., and Imamichi, T. (2007) Hydroxyurea and interleukin-6 synergistically reactivate HIV-1 replication in a latently infected promonocytic cell line via SP1/SP3 transcription factors. J. Biol. Chem. 282, 3594-3604 (Pubitemid 47084494)
44. Imamichi, T., Berg, S. C., Imamichi, H., Lopez, J. C., Metcalf, J. A., Falloon, J., and Lane, H. C. (2000) Relative replication fitness of a high-level 3′-azido-3′-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr → Gly) at codon 69. J. Virol. 74, 10958-10964 (Pubitemid 32223960)
45. Sharova, N., Wu, Y., Zhu, X., Stranska, R., Kaushik, R., Sharkey, M., and Stevenson, M. (2008) Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathog. 4, e1000057
46. Hatzakis, A., Touloumi, G., Karanicolas, R., Karafoulidou, A., Mandalaki, T., Anastassopoulou, C., Zhang, L., Goedert, J. J., Ho, D. D., and Kostrikis, L. G. (2000) Effect of recent thymic emigrants on progression of HIV-1 disease. Lancet 355, 599-604 (Pubitemid 30099465)
47. McNees, A. L., White, Z. S., Zanwar, P., Vilchez, R. A., and Butel, J. S. (2005) Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR. J. Clin. Virol. 34, 52-62 (Pubitemid 41125877)
48. Zhang, X., Brann, T. W., Zhou, M., Yang, J., Oguariri, R. M., Lidie, K. B., Imamichi, H., Huang, D. W., Lempicki, R. A., Baseler, M. W., Veenstra, T. D., Young, H. A., Lane, H. C., and Imamichi, T. (2011) Cutting edge. Ku70 is a novel cytosolicDNAsensor that induces type III rather than type I IFN. J. Immunol. 186, 4541-4545
49. Kamata, M., Nagaoka, Y., and Chen, I. S. (2009) Reassessing the role of APOBEC3G in human immunodeficiency virus type 1 infection of quiescent CD4+ T-cells. PLoS Pathog. 5, e1000342
50. Di Santo, J. P., Kühn, R., and Müller, W. (1995) Common cytokine receptor gamma chain (γc)-dependent cytokines. Understanding in vivo functions by gene targeting. Immunol. Rev. 148, 19-34
51. Noguchi, M., Nakamura, Y., Russell, S. M., Ziegler, S. F., Tsang, M., Cao, X., and Leonard, W. J. (1993) Interleukin-2 receptor gamma chain. A functional component of the interleukin-7 receptor. Science 262, 1877-1880 (Pubitemid 24041859)
52. Russell, S. M., Keegan, A. D., Harada, N., Nakamura, Y., Noguchi, M., Leland, P., Friedmann, M. C., Miyajima, A., Puri, R. K., and Paul, W. E. (1993) Interleukin-2 receptor gamma chain. A functional component of the interleukin-4 receptor. Science 262, 1880-1883
53. Kao, S., Khan, M. A., Miyagi, E., Plishka, R., Buckler-White, A., and Strebel, K. (2003) The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging ofAPOBEC3G(CEM15), a cellular inhibitor of virus infectivity. J. Virol. 77, 11398-11407 (Pubitemid 37271638)
54. Goila-Gaur, R., and Strebel, K. (2008) HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 5, 51
55. Kreisberg, J. F., Yonemoto, W., and Greene, W. C. (2006) Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation. J. Exp. Med. 203, 865-870
56. Soros, V. B., Yonemoto, W., and Greene, W. C. (2007) Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H. PLoS Pathog. 3, e15
57. Wiegand, H. L., Doehle, B. P., Bogerd, H. P., and Cullen, B. R. (2004) A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J. 23, 2451-2458 (Pubitemid 38954852)
58. Xu, H., Svarovskaia, E. S., Barr, R., Zhang, Y., Khan, M. A., Strebel, K., and Pathak, V. K. (2004) A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. Proc. Natl. Acad. Sci. U.S.A. 101, 5652-5657 (Pubitemid 38481211)
59. Bishop, K. N., Holmes, R. K., Sheehy, A. M., Davidson, N. O., Cho, S. J., and Malim, M. H. (2004) Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 14, 1392-1396 (Pubitemid 39081643)
60. Hultquist, J. F., Lengyel, J. A., Refsland, E. W., LaRue, R. S., Lackey, L., Brown, W. L., and Harris, R. S. (2011) Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. J. Virol. 85, 11220-11234
61. Liddament, M. T., Brown, W. L., Schumacher, A. J., and Harris, R. S. (2004) APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr. Biol. 14, 1385-1391 (Pubitemid 39081642)
62. Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., and Malim, M. H. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell 113, 803-809 (Pubitemid 36724943)
63. Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., and Gao, L. (2003) The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424, 94-98 (Pubitemid 36834848)
64. Giri, J. G., Ahdieh, M., Eisenman, J., Shanebeck, K., Grabstein, K., Kumaki, S., Namen, A., Park, L. S., Cosman, D., and Anderson, D. (1994) Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13, 2822-2830 (Pubitemid 24191692)
65. Moriuchi, H., Moriuchi, M., and Fauci, A. S. (1998) Factors secreted by human T lymphotropic virus type I (HTLV-I)-infected cells can enhance or inhibit replication of HIV-1 in HTLV-I-uninfected cells. Implications for in vivo coinfection with HTLV-I and HIV-1. J. Exp. Med. 187, 1689-1697 (Pubitemid 28235110)
66. Böhnlein, E., Siekevitz, M., Ballard, D. W., Lowenthal, J. W., Rimsky, L., Bogérd, H., Hoffman, J., Wano, Y., Franza, B. R., and Greene, W. C. (1989) Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins. J. Virol. 63, 1578-1586 (Pubitemid 19085970)
67. Casoli, C., Pilotti, E., and Bertazzoni, U. (2007) Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression. AIDS Rev 9, 140-149 (Pubitemid 350001485)